These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 37302290)
1. Vital role of SHMT2 in diverse disease. Ma W; Liu R; Zhao K; Zhong J Biochem Biophys Res Commun; 2023 Sep; 671():160-165. PubMed ID: 37302290 [TBL] [Abstract][Full Text] [Related]
2. Roles of Mitochondrial Serine Hydroxymethyltransferase 2 (SHMT2) in Human Carcinogenesis. Zeng Y; Zhang J; Xu M; Chen F; Zi R; Yue J; Zhang Y; Chen N; Chin YE J Cancer; 2021; 12(19):5888-5894. PubMed ID: 34476002 [TBL] [Abstract][Full Text] [Related]
3. Serine Catabolism by SHMT2 Is Required for Proper Mitochondrial Translation Initiation and Maintenance of Formylmethionyl-tRNAs. Minton DR; Nam M; McLaughlin DJ; Shin J; Bayraktar EC; Alvarez SW; Sviderskiy VO; Papagiannakopoulos T; Sabatini DM; Birsoy K; Possemato R Mol Cell; 2018 Feb; 69(4):610-621.e5. PubMed ID: 29452640 [TBL] [Abstract][Full Text] [Related]
4. Serine hydroxymethyltransferase 2: a novel target for human cancer therapy. Xie M; Pei DS Invest New Drugs; 2021 Dec; 39(6):1671-1681. PubMed ID: 34215932 [TBL] [Abstract][Full Text] [Related]
5. Cancer proteome and metabolite changes linked to SHMT2. Tong J; Krieger JR; Taylor P; Bagshaw R; Kang J; Jeedigunta S; Wybenga-Groot LE; Zhang W; Badr H; Mirhadi S; Pham NA; Coyaud É; Yu M; Li M; Cabanero M; Raught B; Maynes JT; Hawkins C; Tsao MS; Moran MF PLoS One; 2020; 15(9):e0237981. PubMed ID: 32903271 [TBL] [Abstract][Full Text] [Related]
6. SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation. Yang X; Wang Z; Li X; Liu B; Liu M; Liu L; Chen S; Ren M; Wang Y; Yu M; Wang B; Zou J; Zhu WG; Yin Y; Gu W; Luo J Cancer Res; 2018 Jan; 78(2):372-386. PubMed ID: 29180469 [TBL] [Abstract][Full Text] [Related]
8. SHMT2 promotes cell viability and inhibits ROS-dependent, mitochondrial-mediated apoptosis via the intrinsic signaling pathway in bladder cancer cells. Zhang Y; Liu Z; Wang X; Jian H; Xiao H; Wen T Cancer Gene Ther; 2022 Oct; 29(10):1514-1527. PubMed ID: 35422087 [TBL] [Abstract][Full Text] [Related]
9. SHMT2 promotes the tumorigenesis of renal cell carcinoma by regulating the m6A modification of PPAT. Huo FC; Xie M; Zhu ZM; Zheng JN; Pei DS Genomics; 2022 Jul; 114(4):110424. PubMed ID: 35798250 [TBL] [Abstract][Full Text] [Related]
10. The role of SHMT2 in modulating lipid metabolism in hepatocytes via glycine-mediated mTOR activation. Choi YJ; Lee G; Yun SH; Lee W; Yu J; Kim SK; Lee BH Amino Acids; 2022 May; 54(5):823-834. PubMed ID: 35212811 [TBL] [Abstract][Full Text] [Related]
11. Induction of serine hydroxymethyltransferase 2 promotes tumorigenesis and metastasis in neuroblastoma. Clark RA; Qiao J; Jacobson JC; Chung DH Oncotarget; 2022; 13():32-45. PubMed ID: 35018218 [TBL] [Abstract][Full Text] [Related]
12. Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells. Ji L; Tang Y; Pang X; Zhang Y Med Sci Monit; 2019 Aug; 25():5823-5832. PubMed ID: 31379360 [TBL] [Abstract][Full Text] [Related]
13. The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. Parsa S; Ortega-Molina A; Ying HY; Jiang M; Teater M; Wang J; Zhao C; Reznik E; Pasion JP; Kuo D; Mohan P; Wang S; Camarillo JM; Thomas PM; Jain N; Garcia-Bermudez J; Cho BK; Tam W; Kelleher NL; Socci N; Dogan A; De Stanchina E; Ciriello G; Green MR; Li S; Birsoy K; Melnick AM; Wendel HG Nat Cancer; 2020; 1():653-664. PubMed ID: 33569544 [TBL] [Abstract][Full Text] [Related]
14. High Expression of Serine Hydroxymethyltransferase 2 Indicates Poor Prognosis of Gastric Cancer Patients. Shi H; Fang X; Li Y; Zhang Y Med Sci Monit; 2019 Oct; 25():7430-7438. PubMed ID: 31581160 [TBL] [Abstract][Full Text] [Related]
15. Human Cytosolic and Mitochondrial Serine Hydroxymethyltransferase Isoforms in Comparison: Full Kinetic Characterization and Substrate Inhibition Properties. Tramonti A; Nardella C; di Salvo ML; Barile A; Cutruzzolà F; Contestabile R Biochemistry; 2018 Dec; 57(51):6984-6996. PubMed ID: 30500180 [TBL] [Abstract][Full Text] [Related]
16. Structural basis of inhibition of the human serine hydroxymethyltransferase SHMT2 by antifolate drugs. Scaletti E; Jemth AS; Helleday T; Stenmark P FEBS Lett; 2019 Jul; 593(14):1863-1873. PubMed ID: 31127856 [TBL] [Abstract][Full Text] [Related]
17. The catalytic activity of serine hydroxymethyltransferase is essential for de novo nuclear dTMP synthesis in lung cancer cells. Giardina G; Paone A; Tramonti A; Lucchi R; Marani M; Magnifico MC; Bouzidi A; Pontecorvi V; Guiducci G; Zamparelli C; Rinaldo S; Paiardini A; Contestabile R; Cutruzzolà F FEBS J; 2018 Sep; 285(17):3238-3253. PubMed ID: 30035852 [TBL] [Abstract][Full Text] [Related]
18. Extracellular serine empowers epidermal proliferation and psoriasis-like symptoms. Cappello A; Mancini M; Madonna S; Rinaldo S; Paone A; Scarponi C; Belardo A; Zolla L; Zuccotti A; Panatta E; Pallotta S; Annicchiarico-Petruzzelli M; Albanesi C; Cutruzzolà F; Wang L; Jia W; Melino G; Candi E Sci Adv; 2022 Dec; 8(50):eabm7902. PubMed ID: 36525488 [TBL] [Abstract][Full Text] [Related]
20. SHMT2 Drives the Progression of Colorectal Cancer by Regulating UHRF1 Expression. Cui X; Cui Y; Du T; Jiang X; Song C; Zhang S; Ma C; Liu Y; Ni Q; Gao Y; Wang G Can J Gastroenterol Hepatol; 2022; 2022():3758697. PubMed ID: 35211429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]